Oxford Immunotec plans to bring its research-use COVID test to South Korea
Photo/Google
Oxford Immunotec's Marlborough offices
Oxford Immunotec, a diagnostics company based in both Marlborough and the United Kingdom, has entered a memorandum of understanding to bring its research-use-only T-SPOT Discovery SARS-CoV-2 to South Korea, the company announced on Monday.
The MOU is between Green Cross Medical Science Corp., which will market and sell the test, as well as MESDIA Co., Ltd., both of South Korea, which will import the tests. Oxford Immunotec Korea will provide broad support for its test kit.
“This MOU means that the T-SPOT Discovery SARS-CoV-2 kit will be available to more researchers and multiple biopharmaceutical companies that are developing innovative treatments and vaccines across South Korea, which we believe will make a significant contribution towards informing how we can better manage the ongoing pandemic in the country,” said Walt Ling, vice president of commercial APAC for Oxford Immunotec, in a statement.
The test kit in question is already available for research use in Europe and the United States.
WBJ Web Partners
Most Recent
Most Recent
0 Comments